Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07470762 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: HS-10542
DRUG: HS-10542
DRUG: HS-10542

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.